Across TCGA pan-cancer cohorts, RNA5SP189 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNA5SP189 data layer.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RNA5SP189 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP189 expression acts as an unfavorable survival marker.
LUSC and ESCA are the cancer types where RNA5SP189 RNA most reproducibly stratifies survival.